ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.

Junya Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.